Ron Squarer, CEO at ARRAY BIOPHARMA INC (ARRY), sold 402,759 shares at $17.74 ($7.3M) on 2018-06-27, disclosed to the SEC on 2018-06-29.
Open-market sale of $7.3M ARRY by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.74 | 43,628 | $774K | 10.7% |
| 2 | $17.74 | 43,628 | $774K | 10.7% |
| 3 | $18.03 | 140,625 | $2.5M | 35.0% |
| 4 | $18.03 | 140,625 | $2.5M | 35.0% |
| 5 | $18.50 | 34,253 | $634K | 8.7% |
| Total | $18.01 avg | 402,759 |
| $7.3M |
| 100% |
| Filing → |
| ARRY | SELL | 2019-02-01 | $6.0M | — | Filing → |
| ARRY | SELL | 2017-12-19 | $8.9M | — | Filing → |
| ARRY | SELL | 2015-03-04 | $330K | — | Filing → |